medication adherence
Conditions
Interventions
Balto is a recently developed digital platform that provides patients with accessible, tailored information about their condition and prescribed medication, aiming to support medication adherence.
Sponsors
Obseq
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: All people who started treatment for cardiovascular risk management within the last six months prior to the start of the study (extendable to twelve months if needed for recruitment), aged = 18 years, are eligible for inclusion. Eligible medication classes include antihypertensives (thiazide diuretics, ACE inhibitors, angiotensin receptor blockers, dihydropyridines, selective beta blockers), lipid-lowering medications (statins, ezetimibe), glucose-lowering medications, and antithrombotics. Only individuals who can understand and read Dutch, have a valid email address, and are able to create a digital account will be included.
Exclusion criteria
Exclusion criteria: Patients whose medication care has been transferred to nursing staff, such as in nursing homes, are excluded. Patients with contra-indication heart failure are excluded. Furthermore, patients using a medicine role are excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Treatment adherence measured using the MARS-5 questionnaire at 9 months follow-up. | — |
Secondary
| Measure | Time frame |
|---|---|
| Treatment adherence, measured using the MARS-5 questionnaire at 3- and 6-months follow-up; Discontinuation of preventive cardiovascular medication, as reported by the patient, at 3-, 6-, and 9-months follow-up. Relevant cardiovascular risk parameters; Number of contact moments with pharmacy or general practice staff, as reported by the patient; Perceived health and satisfaction with received information: questionnaires; Attitudes towards Balto platform; Intervention engagement. | — |
Countries
Netherlands
Contacts
Public ContactK Taxis
Obseq
Outcome results
None listed